Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Paclitaxel, Gemcitabine +/- Avastin in Unknown Primary Tumors
NCT00458315Phase 2Withdrawn
- Sponsor
- Rigshospitalet
- Start
- May 2007
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in cancer of unknown primary (CUP), sponsored by Rigshospitalet. Planned start May 2007; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00458315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458315.